NewslettersHuman Immunology NewsGilead and EVOQ Therapeutics Announce Collaboration to Advance ImmunotherapiesBy Laurisa Dohm - January 3, 20230140Gilead Sciences, Inc. and EVOQ Therapeutics, Inc. announced a collaboration and licensing agreement to advance EVOQ’s proprietary technology for the treatment of rheumatoid arthritis and lupus.[Gilead Sciences Inc.]Full Article